Trials / Completed
CompletedNCT00617084
Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent
RESOLUTE-III All-comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,292 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The RESOLUTE-III Allcomers trial is a prospective, multicenter, randomized, two-arm, international, non-inferiority, open-label study with 2300 patients at 15-20 centers. The study is a "real world, all comers" study. Primary objective: to compare the Medtronic Endeavor-Resolute (Zotarolimus-Eluting stent) system with the Abbott XIENCE V (Everolimus-Eluting stent) system with respect to cardiac death, myocardial infarction (not clearly attributable to a non-target vessel), Target Lesion Revascularization at 1 year in a "real world" patient population.
Detailed description
The RESOLUTE-III Allcomers trial is a prospective, multicenter, randomized, two-arm, international, non-inferiority, open-label study with 2300 patients at 15-20 centers. The study is a "real world, all comers" study. Primary objective: to compare the Medtronic Endeavor-Resolute (Zotarolimus-Eluting stent) system with the Abbott XIENCE V (Everolimus-Eluting stent) system with respect to cardiac death, myocardial infarction (not clearly attributable to a non-target vessel), Target Lesion Revascularization at 1 year in a "real world" patient population. Study hypothesis: To determine whether the Zotarolimus-Eluting stent (Medtronic Endeavor-Resolute) is non-inferior to the Everolimus-eluting stent (Abbott XIENCE V) in terms of the primary endpoint at 12 months after stent implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic Endeavor Resolute | Medtronic Endeavor Resolute |
| DEVICE | Abbott Xience V | Abbott Xience V |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-05-01
- Completion
- 2014-02-01
- First posted
- 2008-02-15
- Last updated
- 2014-06-06
- Results posted
- 2011-05-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00617084. Inclusion in this directory is not an endorsement.